Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antioxidant defense proteins comprise a diverse group of enzymes and non-enzymatic proteins dedicated to maintaining cellular redox homeostasis by neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS) [1]. Key members include superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), and the thioredoxin system, which work coordinately to prevent oxidative damage to DNA, proteins, and lipids [2]. Many of these proteins are transcriptionally regulated by the Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, which acts as a master regulator of the endogenous antioxidant response [3]. Dysregulation of these proteins is implicated in a wide range of diseases, including neurodegenerative disorders, cardiovascular diseases, and chronic inflammatory conditions [4]. In oncology, antioxidant defense proteins play a dual role: they protect normal cells from malignant transformation but can also be hijacked by tumor cells to survive metabolic stress and resist chemotherapy [5]. Therapeutic interventions often focus on inducing these endogenous defenses using Nrf2 activators like bardoxolone methyl or employing small-molecule mimetics of enzymes like SOD [6]. However, excessive suppression of ROS can lead to "reductive stress," potentially interfering with essential signaling pathways required for normal physiological functions [7]. [1] Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. Oxford University Press; 2015. [2] Sies H, et al. Nat Rev Mol Cell Biol. 2017;18(6):355-365. [3] He F, et al. QJM. 2020;113(11):771-779. [4] Forman HJ, Zhang H. Nat Rev Drug Discov. 2021;20(9):689-709. [5] Harris IS, DeNicola GM. Trends Cancer. 2020;6(8):678-687. [6] Kensler TW, et al. Top Curr Chem. 2013;329:163-177. [7] Xiao W, Loscalzo J. Antioxid Redox Signal. 2020;32(18):1330-1347.
Induction of endogenous antioxidant gene expression via the Nrf2-KEAP1 pathway or direct catalytic scavenging of reactive oxygen species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant defense proteins.